SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chiara Della Pepa, Giuseppe Tonini, Daniele Santini, Simona Losito, Carmela Pisano, Marilena Di Napoli, Sabrina Chiara Cecere, Piera Gargiulo, Sandro Pignata, Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy, Cancer Treatment Reviews, 2015, 41, 2, 136

    CrossRef

  2. 2
    Robertson Mackenzie, Stefan Kommoss, Boris J. Winterhoff, Benjamin R. Kipp, Joaquin J. Garcia, Jesse Voss, Kevin Halling, Anthony Karnezis, Janine Senz, Winnie Yang, Elena-Sophie Prigge, Miriam Reuschenbach, Magnus Von Knebel Doeberitz, Blake C. Gilks, David G. Huntsman, Jamie Bakkum-Gamez, Jessica N. McAlpine, Michael S. Anglesio, Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms, BMC Cancer, 2015, 15, 1

    CrossRef

  3. 3
    Greta Gandolfi, Valentina Sancisi, Simonetta Piana, Alessia Ciarrocchi, Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma, International Journal of Cancer, 2015, 137, 3
  4. 4
    Reinou S. Groen, David M. Gershenson, Amanda Nickles Fader, Updates and emerging therapies for rare epithelial ovarian cancers: One size no longer fits all, Gynecologic Oncology, 2015, 136, 2, 373

    CrossRef

  5. 5
    Gregory A Ryslik, Yuwei Cheng, Kei-Hoi Cheung, Yorgo Modis, Hongyu Zhao, A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations, BMC Bioinformatics, 2014, 15, 1, 86

    CrossRef

  6. 6
    Gábor Méhes, Gábor Irsai, Judit Bedekovics, Lívia Beke, Ferenc Fazakas, Tímea Rózsa, Csongor Kiss, Activating BRAF V600E Mutation in Aggressive Pediatric Langerhans Cell Histiocytosis, The American Journal of Surgical Pathology, 2014, 38, 12, 1644

    CrossRef

  7. 7
    S. Darb-Esfahani, C. Denkert, M. Dietel, Aktuelle Aspekte zur Tumorigenese und Ätiologie, Der Onkologe, 2014, 20, 7, 642

    CrossRef

  8. 8
    M. A. Bookman, C. B. Gilks, E. C. Kohn, K. O. Kaplan, D. Huntsman, C. Aghajanian, M. J. Birrer, J. A. Ledermann, A. M. Oza, K. D. Swenerton, Better Therapeutic Trials in Ovarian Cancer, JNCI Journal of the National Cancer Institute, 2014, 106, 4, dju029

    CrossRef

  9. 9
    Rachel N. Grisham, Gopa Iyer, Evis Sala, Qin Zhou, Alexia Iasonos, Deborah DeLair, David M. Hyman, Carol Aghajanian, Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer, International Journal of Gynecological Cancer, 2014, 24, 6, 1010

    CrossRef

  10. 10
    Marcin M. Machnicki, Tomasz Stoklosa, BRAF — A new player in hematological neoplasms, Blood Cells, Molecules, and Diseases, 2014, 53, 1-2, 77

    CrossRef

  11. 11
    Felix Zeppernick, Laura Ardighieri, Charlotte G. Hannibal, Russell Vang, Jette Junge, Susanne K. Kjaer, Rugang Zhang, Robert J. Kurman, Ie-Ming Shih, BRAF Mutation Is Associated With a Specific Cell Type With Features Suggestive of Senescence in Ovarian Serous Borderline (Atypical Proliferative) Tumors, The American Journal of Surgical Pathology, 2014, 38, 12, 1603

    CrossRef

  12. 12
    M. Devouassoux-Shisheboran, Cancers de l’ovaire : la biologie moléculaire, Oncologie, 2014, 16, 6, 306

    CrossRef

  13. 13
    Charlie Gourley, John Farley, Diane M. Provencher, Sandro Pignata, Linda Mileshkin, Philipp Harter, Johanna Maenpaa, Jae-Weon Kim, Eric Pujaide-Lauraine, Rosalind M. Glasspool, Isabelle Ray-Coquard, David Gershenson, Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian and Primary Peritoneal Low-Grade Serous Carcinomas, International Journal of Gynecological Cancer, 2014, 24, S9

    CrossRef

  14. 14
    Katerina Dvorak, Birte Aggeler, John Palting, Penny McKelvie, Andrew Ruszkiewicz, Paul Waring, Immunohistochemistry with the anti-BRAF V600E (VE1) antibody, Pathology, 2014, 46, 6, 509

    CrossRef

  15. 15
    Mauricio Burotto, Victoria L. Chiou, Jung-Min Lee, Elise C. Kohn, The MAPK pathway across different malignancies: A new perspective, Cancer, 2014, 120, 22
  16. 16
    E. C. Kohn, S. Romano, J.- M. Lee, Clinical implications of using molecular diagnostics for ovarian cancers, Annals of Oncology, 2013, 24, suppl 10, x22

    CrossRef

  17. 17
    Björn Nodin, Nooreldin Zendehrokh, Magnus Sundström, Karin Jirström, Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer, Diagnostic Pathology, 2013, 8, 1, 106

    CrossRef

  18. 18
    Sahar Pakneshan, Ali Salajegheh, Robert Anthony Smith, Alfred King-Yin Lam, Clinicopathological relevance of BRAF mutations in human cancer, Pathology, 2013, 45, 4, 346

    CrossRef

  19. 19
    J.S. Ross, S.M. Ali, K. Wang, G. Palmer, R. Yelensky, D. Lipson, V.A. Miller, D. Zajchowski, L.K. Shawver, P.J. Stephens, Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies, Gynecologic Oncology, 2013, 130, 3, 554

    CrossRef

  20. 20
    Yvonne T Tsang, Michael T Deavers, Charlotte C Sun, Suet-Yan Kwan, Eric Kuo, Anais Malpica, Samuel C Mok, David M Gershenson, Kwong-Kwok Wong, KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma, The Journal of Pathology, 2013, 231, 4
  21. 21
    Hironobu Shigaki, Yoshifumi Baba, Masayuki Watanabe, Keisuke Miyake, Asuka Murata, Shiro Iwagami, Takatsugu Ishimoto, Masaaki Iwatsuki, Naoya Yoshida, Hideo Baba, KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review, Annals of Surgical Oncology, 2013, 20, S3, 485

    CrossRef

  22. 22
    Ignacio Romero, Charlotte C. Sun, Kwong K. Wong, Robert C. Bast, David M. Gershenson, Low-grade serous carcinoma: New concepts and emerging therapies, Gynecologic Oncology, 2013, 130, 3, 660

    CrossRef

  23. 23
    P. Rescigno, I. Cerillo, R. Ruocco, C. Condello, S. De Placido, M. Pensabene, New Hypothesis on Pathogenesis of Ovarian Cancer Lead to Future Tailored Approaches, BioMed Research International, 2013, 2013, 1

    CrossRef

  24. 24
    Elise C. Kohn, Jean Hurteau, Ovarian cancer , Cancer, 2013, 119, 3
  25. 25
    Jatinderpal K Kalsi, Ranjit Manchanda, Usha Menon, Screening for gynecological cancers, Expert Review of Obstetrics & Gynecology, 2013, 8, 2, 143

    CrossRef